KMITL

Permanent URI for this communityhttps://dspace.kmitl.ac.th/handle/kmitl/1

Browse

Search Results

Now showing 1 - 2 of 2
  • Some of the metrics are blocked by your 
    Item type:Publication,
    A comparative study of non-enzymatic glucose detection in artificial human urine and human urine specimens by using mesoporous bimetallic cobalt-iron supported N-doped graphene biosensor based on differential pulse voltammetry
    (2019-05-01)
    Janyasupab, Metini
    ;
    Liu, Chen Wei
    ;
    Chanlek, Narong
    ;
    Chio-Srichan, Sirinart
    ;
    Promptmas, Chamras
    Development of non-invasive glucose measurement allows future advancement of smart sensing platform for diagnostic technology. Especially for endocrine disorders, advanced kidney diseases, and diabetes, monitoring excessive glucose level in urine can provide invaluable information for clinical prognosis and preventive healthcare. Herein, we present a comparative electrochemical study of cobalt/iron (CoFe) catalyst on nitrogen-doped graphene (NG) for non-enzymatic glucose detection, carried out in physiological pH urine including (i) modified artificial urine medium (mAUM), (ii) commercial standard urine (Surine), and (iii) human urine specimens. With no requirement of strong alkaline addition, catalytic properties of CoFe-NG were assessed by using cyclic voltammetry (CV) and differential pulse voltammetry (DPV) on a glassy carbon rotating disk electrode. Upon successive glucose additions from 0 to 3 mM, DPV results revealed two anodic peaks at +0.18 V and +0.42 V versus Ag/AgCl, corresponding to Co<sup>3+</sup> and Co<sup>4+</sup> as a result of glucose binding in urine. By evaluating at +0.18 V, the sensitivities of CoFe-NG were estimated to be 16.77 (R<sup>2</sup> = 0.987), 45.36 (R<sup>2</sup> = 0.988), and 20.26 (R<sup>2</sup> = 0.991) μA mM<sup>−1</sup> cm<sup>−2</sup> with the limit of detection of 0.25, 0.07, and 0.19 mM in mAUM, Surine, and human urine specimen with low serum creatinine, respectively. Furthermore, the effects of CoFe on graphene (G) and carbon Vulcan XC-72 (C) were also studied in comparison of NG on the bimetal. Interestingly, CoFe-C showed a good electrochemical trend in glucose detection in urine. However, negligible catalytic activity was presented in CoFe-G. Thus, electrochemical responses of CoFe-C were also further studied in the comparison of CoFe-NG in each type of urine. Overall, CoFe-NG outperformed CoFe-C in all types of urine and exhibited an excellent anti-interference property toward uric acid, thereby suggesting great potential for the next generation of glucose sensing platform in urine.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Development of non-enzymatic N-doped graphene supported cobalt/iron amperometric based sensor for glucose detection in urine
    (2019-01-24)
    Janyasupab, Metini
    ;
    Promptmas, Chamras
    We presented a cost-effective design of electrochemical based biosensor for non-enzymatic glucose detection in urine. By incorporating low-cost, non-precious cobalt (Co)/iron (Fe) metals, the sensor was employed onto the three-electrode system for quantifying glucose level from 0 to 3.25 mM in artificial urine medium and clinical simulated urine solution, namely, Surine. In particular, the fabricated CoFe nanoparticles on N-doped graphene (NG) biosensor was assessed electrochemical performances by cyclic voltammetry and amperometry at applied potential of +0.90 V versus Ag/AgCl, in comparison with that of CoFe on carbon supported. Based on the results, it was found that two processes of catalytic oxidation and oxide depletion are involved in glucose detection. More importantly, the as-prepared biosensor exhibited an outstanding sensitivity of 476.67 µA.cm<sup>-2</sup>.mM<sup>-1</sup> with R<sup>2</sup> of 0.9974 in Surine. Furthermore, the low limit of detection was estimated to be 37.7 µM (signal-to-noise ratio of 3) with an excellent anti-interference property toward ascorbic acid, uric acid, and chlorine ions, providing a promising advancement for future glucose measurement in urine, applicable for sustainable diabetic prognosis and management.